Overexpression of Bcl-xL can lead to the resistance of chondrosarcoma cells to conventional chemotherapy [33], which also occurs in colon cancer [34], liver cancer [35], and non-Hodgkin’s lymphoma [36]. This evidence concerns the gene BCL2L1 and chondrosarcoma.